ADAMIS PHARMACEUTICALS CORP
COM NEW · CUSIP 00547W208
0
institutional holders
-48 vs Q1 2023
—reported value*
0 new
0 added
0 reduced
48 sold out
net sold ≈ $3.2m (-27.6m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 44 |
| Q4 2022 | 49 |
| Q1 2023 | 48 |
| Q2 2023 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 21 | 16 |
| Q1 2023 | 14 | 13 |
| Q2 2023 | 0 | 48 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
CallsPuts
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2022 | $169.0k | $4.0k | 0.02 |
| Q4 2022 | $141.9k | $5.3k | 0.04 |
| Q1 2023 | $17.0k | $487 | 0.03 |
| Q2 2023 | $0 | $0 | — |
Biggest buyers
| None |
Biggest sellers
| ARMISTICE CAPITAL, LLC | Sold out | -14.5m |
| VANGUARD GROUP INC | Sold out | -6.5m |
| BlackRock Inc. | Sold out | -2.8m |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -1.3m |
| STATE STREET CORP | Sold out | -475.4k |
| CITADEL ADVISORS LLC | Sold out | -327.2k |
| Tower Research Capital LLC (TRC) | Sold out | -268.8k |
| NORTHERN TRUST CORP | Sold out | -244.6k |
| HRT FINANCIAL LP | Sold out | -143.9k |
| UBS Group AG | Sold out | -128.2k |
Holders, Q2 2023
| Manager | Shares | Change |
|---|